2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   12

Issue No. :  6

Year :  2019

Pages :   3017-3023

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Formulation and In vitro Evaluation of Matrix Tablets containing Pioglitazone

Address:   Dr. C C Patil1*, Shedyal Bhairappa2, Vijapure Vitthal K2
1B.L.D.E.A’s SSM College of Pharmacy and Research Centre, Vijayapura,-586103
2S.J.M College of Pharmacy, S J M Campus, Chitradurga,-577502
*Corresponding Author
DOI No: 10.5958/0974-360X.2019.00510.9

The objective of the study was to develop matrix tablet of Pioglitazone. Tablets of Pioglitazone were prepared by the wet granulation method using polymers like Hydroxy propyl methylcellulose, Sodium CMC, Methyl cellulose, Ethyl cellulose in different ratios. Matrix tablet were evaluated by different methods for parameters such as thickness, hardness, weight uniformity, drug content uniformity, and in vitro drug release studies, stability studies. The tablets were evaluated for in vitro release in pH7.4 phosphate buffer for 12 hours in standard dissolution apparatus. Mucoadhesion strength is increased with increase in the concentration of HPMC. In order to determine the mode of release, the data was subjected to Zero order, First order, Higuchi and Peppas diffusion model. Short term stability studies on the promising formulation indicated that, there are no significant changes in drug content. IR spectroscopic indicated that there are no drug- excipients interaction. All the granules of the formulation showed in compliance with Pharmacopeial Standards. The developed sustain released matrix tablet of Pioglitazone drug showed 12 hours of drug release and overcome the disadvantage of conventional tablets.
Matrix tablet: Pioglitazone, HPMC, Sodium CMC, Methyl cellulose, Ethyl cellulose.
C C Patil, Shedyal Bhairappa, Vijapure Vitthal K. Formulation and In vitro Evaluation of Matrix Tablets containing Pioglitazone. Research J. Pharm. and Tech. 2019; 12(6): 3017-3023.
[View HTML]     

Visitor's No. :   688957